Business
Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
NEWPORT BEACH, Calif., February 17, 2026--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its fourth quarter and full-year 2025 financial results on Tuesday, March 3, 2026, after the U.S. financial markets close.
About this update from Evolus, Inc. Common Stock
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/975cbf30f7e22c350a34f7ce7fafc77d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/73qrTCUws9Q2C52biYqesg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/975cbf30f7e22c350a34f7ce7fafc77d","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Pj.RwoAH4JnGhGgxlGMmGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/975cbf30f7e22c350a34f7ce7fafc77d","width":1024,"height":512}},"lazy":false},{"type":"text","content":"NEWPORT BEACH, Calif., February 17, 2026--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its fourth quarter and full-year 2025 financial results on Tuesday, March 3, 2026, after the U.S. financial markets close.","length":343,"tagName":"p"},{"type":"text","content":"Evolus management will host a conference call and live webcast to discuss these results at 4:30 p.m. ET that same day. A question-and-answer session will follow management’s remarks.","length":182,"tagName":"p"},{"type":"text","content":"To participate in the conference call, dial (877) 407-6184 (U.S.) or (201) 389-0877 (international) or connect live via webcast on the Investor Relations page of the Evolus website here.","length":186,"tagName":"p"},{"type":"text","content":"Following the completion of the call, a telephonic replay can be accessed by dialing (877) 660-6853 (U.S.) or (201) 612-7415 (international) and using conference number 13758456. An archived webcast can also be accessed on the Investor Relations page of the Evolus website at www.evolus.com.","length":291,"tagName":"p"},{"type":"text","content":"About Evolus, Inc.","length":18,"tagName":"p"},{"type":"text","content":"Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuv...